Share to Raise Cancer Awareness

博金斯基: 癌症是严重的企业记录片 (Burzynski: Cancer Is Serious Business)

A 105-minute documentary of a medical doctor and Ph.D biochemist named Dr. Stanislaw Burzynski who won the largest and possibly the most convoluted and intriguing legal battle against the Food & Drug Administration in American history. His victorious battles with the United States government were centered on Dr. Burzynski’s belief in and commitment to his gene-targeted cancer medicines he discovered in the 1970’s called Antineoplastons, which have currently completed Phase II FDA-supervised clinical trials in 2009 and will begin the final phase of testing in 2010. When Antineoplastons are approved, it will mark the first time in history a single scientist, not a pharmaceutical company, will hold the exclusive patent and distribution rights on a paradigm shifting, life-saving medical breakthrough. Antineoplastons are responsible for curing some of the most incurable forms of terminal cancer. Various cancer survivors are presented in the film that chose his treatment instead of surgery, chemotherapy or radiation – with full disclosure of original medical records to support their diagnosis and recovery. One form of cancer – “diffuse, intrinsic, childhood brainstem glioma” has never before been cured in any experimental clinical trial in the history of medicine. Antineoplastons hold the first cures in history – dozens of them. Burzynski takes the audience through the treacherous, yet victorious, 14-year journey both Dr. Burzynski and his patients have had to endure in order to obtain FDA-approved clinical trials of Antineoplastons. However, what was revealed a few years after Dr. Burzynski won his freedom, helps to paint a more coherent picture regarding the true motivation of the U.S. government’s relentless prosecution of Stanislaw Burzysnki, M.D., Ph.D.

As of 2009, 12 phase 2 clinical trials have been completed for Dr. Burzynski’s antineoplastons, and the FDA has granted permission to being Phase 3 trials. However, Many cancer drugs currently on the market were approved for sale by the FDA without undergoing phase 3 trials, and after showing only limited results.

In April of 2012, the Texas Medical Board will once again attempt to shut down Burzynski’s practice.


生物化学博士/医师斯坦尼斯拉博金斯基(Dr. Stanislaw Burzynski)亲手单独在14年的法律战争打败美国食品及药物管理局(FDA). Burzynski医生在1970年代创始抗瘤酮(Antineoplastons)基因靶向抗癌药物. 20年过陈, 博金斯基许多癌症病人经过Antineoplastons癌症治疗都不用化疗或放射线疗法而康复. 但FDA不合理的断阻挡博金斯基的Antineoplastons治疗法正式批准以提起诉讼不当治疗. 假如Antineoplastons得到FDA批准, 会成为医学历史第一次一个单独医生而不是大型制药公司, 争取药学上的重大突破独家专利和经销权.



(special thanks to Mantesh)

Related Posts

Recommended Post